Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2025-12-26 @ 9:15 PM
Study NCT ID:
NCT00209950
Status:
COMPLETED
Last Update Posted:
2007-03-30
First Post:
2005-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Prospective Open-Label Extension Study of Gaboxadol in Primary Insomnia
Sponsor:
H. Lundbeck A/S
Organization:
Study Overview
Official Title:
A Prospective Open-Label Extension Study (to Study 99784) of Gaboxadol in Primary Insomnia
Status:
COMPLETED
Status Verified Date:
2007-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the safety and tolerability of gaboxadol in primary insomnia
Detailed Description:
To evaluate long-term safety of gaboxadol in healthy adults.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: